Cargando…
Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review
Background: Ischemic stroke is a common occurrence in patients with concomitant malignancy. Systemic thrombolysis is often contraindicated in these patients, and mechanical thrombectomy (MT) is the preferred method of intervention. This review aims to collect the available data on the safety and eff...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410462/ https://www.ncbi.nlm.nih.gov/pubmed/36012933 http://dx.doi.org/10.3390/jcm11164696 |
_version_ | 1784775099173306368 |
---|---|
author | Aloizou, Athina-Maria Richter, Daniel Charles James, Jeyanthan Lukas, Carsten Gold, Ralf Krogias, Christos |
author_facet | Aloizou, Athina-Maria Richter, Daniel Charles James, Jeyanthan Lukas, Carsten Gold, Ralf Krogias, Christos |
author_sort | Aloizou, Athina-Maria |
collection | PubMed |
description | Background: Ischemic stroke is a common occurrence in patients with concomitant malignancy. Systemic thrombolysis is often contraindicated in these patients, and mechanical thrombectomy (MT) is the preferred method of intervention. This review aims to collect the available data on the safety and efficacy of MT in cancer patients (CPs).Methods: The PubMed/MEDLINE and SCOPUS databases were systematically searched for studies assessing safety (mortality, intracranial hemorrhage) and efficacy (reperfusion, functional outcome) indices in CPs receiving MT. Potentially relevant parameters examined in solitary studies were also extracted (e.g., stroke recurrence, brain malignancy).Results: A total of 18 retrospective studies of various methodologies and objectives were identified. Rates of in-hospital mortality, intracranial hemorrhage of any kind, reperfusion rates, and discharge condition did not seem to present any considerable differences between CPs and patients without cancer. On the contrary, 90-day mortality was higher and 90-day functional independence was lower in CPs. Three studies on cancer-related stroke (no other identifiable etiology and high D-dimer levels in the presence of active cancer) showed constant tendencies towards unfavorable conditions. Conclusions: Per the available evidence, MT appears to be a safe treatment option for CPs. It is still unclear whether the 90-day mortality and outcome rates are more heavily influenced by the malignancy and not the intervention itself, so MT can be considered in CPs with prospects of a good functional recovery, undertaking an individualized approach. |
format | Online Article Text |
id | pubmed-9410462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94104622022-08-26 Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review Aloizou, Athina-Maria Richter, Daniel Charles James, Jeyanthan Lukas, Carsten Gold, Ralf Krogias, Christos J Clin Med Systematic Review Background: Ischemic stroke is a common occurrence in patients with concomitant malignancy. Systemic thrombolysis is often contraindicated in these patients, and mechanical thrombectomy (MT) is the preferred method of intervention. This review aims to collect the available data on the safety and efficacy of MT in cancer patients (CPs).Methods: The PubMed/MEDLINE and SCOPUS databases were systematically searched for studies assessing safety (mortality, intracranial hemorrhage) and efficacy (reperfusion, functional outcome) indices in CPs receiving MT. Potentially relevant parameters examined in solitary studies were also extracted (e.g., stroke recurrence, brain malignancy).Results: A total of 18 retrospective studies of various methodologies and objectives were identified. Rates of in-hospital mortality, intracranial hemorrhage of any kind, reperfusion rates, and discharge condition did not seem to present any considerable differences between CPs and patients without cancer. On the contrary, 90-day mortality was higher and 90-day functional independence was lower in CPs. Three studies on cancer-related stroke (no other identifiable etiology and high D-dimer levels in the presence of active cancer) showed constant tendencies towards unfavorable conditions. Conclusions: Per the available evidence, MT appears to be a safe treatment option for CPs. It is still unclear whether the 90-day mortality and outcome rates are more heavily influenced by the malignancy and not the intervention itself, so MT can be considered in CPs with prospects of a good functional recovery, undertaking an individualized approach. MDPI 2022-08-11 /pmc/articles/PMC9410462/ /pubmed/36012933 http://dx.doi.org/10.3390/jcm11164696 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Systematic Review Aloizou, Athina-Maria Richter, Daniel Charles James, Jeyanthan Lukas, Carsten Gold, Ralf Krogias, Christos Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review |
title | Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review |
title_full | Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review |
title_fullStr | Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review |
title_full_unstemmed | Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review |
title_short | Mechanical Thrombectomy for Acute Ischemic Stroke in Patients with Malignancy: A Systematic Review |
title_sort | mechanical thrombectomy for acute ischemic stroke in patients with malignancy: a systematic review |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410462/ https://www.ncbi.nlm.nih.gov/pubmed/36012933 http://dx.doi.org/10.3390/jcm11164696 |
work_keys_str_mv | AT aloizouathinamaria mechanicalthrombectomyforacuteischemicstrokeinpatientswithmalignancyasystematicreview AT richterdaniel mechanicalthrombectomyforacuteischemicstrokeinpatientswithmalignancyasystematicreview AT charlesjamesjeyanthan mechanicalthrombectomyforacuteischemicstrokeinpatientswithmalignancyasystematicreview AT lukascarsten mechanicalthrombectomyforacuteischemicstrokeinpatientswithmalignancyasystematicreview AT goldralf mechanicalthrombectomyforacuteischemicstrokeinpatientswithmalignancyasystematicreview AT krogiaschristos mechanicalthrombectomyforacuteischemicstrokeinpatientswithmalignancyasystematicreview |